RXI Pharma (RXII) Tops Q4 EPS by 1c

RXI Pharma (NASDAQ: RXII) reported Q4 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on RXI Pharma (RXII) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Change in Nonfarm Payrolls (Sep) 29K vs 90K Expected, Unemployment Rate 4.2%
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'